Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators

Identifieur interne : 000031 ( France/Analysis ); précédent : 000030; suivant : 000032

Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators

Auteurs : Gang Cheng [États-Unis] ; Jacek Zielonka [États-Unis] ; Micael Hardy [France] ; Olivier Ouari [France] ; Christopher R. Chitambar [États-Unis] ; Michael B. Dwinell [États-Unis] ; Balaraman Kalyanaraman [États-Unis]

Source :

RBID : PMC:6544408

Abstract

ABSTRACT

We demonstrate that combined treatment with metformin (Met) or its mitochondria-targeted analog, mito-metformin (Mito-Met), and various iron chelators synergistically inhibits proliferation of pancreatic and triple-negative breast cancer cells. Previously, we reported that Met (at millimolar levels) and Mito-Met (at micromolar levels) inhibited pancreatic cancer cell proliferation. Inhibition of mitochondrial complex I and mitochondrial oxidative phosphorylation (OXPHOS) through stimulation of mitochondrial redox signaling was proposed as a key mechanism for decreased cancer cell proliferation. Because of its poor bioavailability, the use of Met as a “stand-alone” antitumor drug has been questioned. Iron chelators such as deferasirox (DFX) and dexrazoxane (DXR) exhibit antiproliferative effects in cancer cells. The potency of Met and Mito-Met was synergistically enhanced in the presence of iron chelators, DFX, N,N'-bis(2-hydroxyphenyl)ethylendiamine-N,N'-diacetic acid (HBED), and deferoxamine (DFO). Met, DXR (also ICRF-187), and DFO are FDA-approved drugs for treating diabetes, decreasing the incidence and severity of cardiotoxicity following chemotherapy, and mitigating iron toxicity, respectively. Thus, the synergistic antiproliferative effects of Met and Met analogs and iron chelators may have significant clinical relevance in cancer treatment. These findings may have implications in other OXPHOS-mediated cancer therapies.


Url:
DOI: 10.18632/oncotarget.26943
PubMed: 31191823
PubMed Central: 6544408


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:6544408

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators</title>
<author>
<name sortKey="Cheng, Gang" sort="Cheng, Gang" uniqKey="Cheng G" first="Gang" last="Cheng">Gang Cheng</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A2">Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zielonka, Jacek" sort="Zielonka, Jacek" uniqKey="Zielonka J" first="Jacek" last="Zielonka">Jacek Zielonka</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A2">Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A3">Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hardy, Micael" sort="Hardy, Micael" uniqKey="Hardy M" first="Micael" last="Hardy">Micael Hardy</name>
<affiliation wicri:level="3">
<nlm:aff id="A7">Aix Marseille University, CNRS, ICR, UMR 7273, Marseille 13013, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix Marseille University, CNRS, ICR, UMR 7273, Marseille 13013</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ouari, Olivier" sort="Ouari, Olivier" uniqKey="Ouari O" first="Olivier" last="Ouari">Olivier Ouari</name>
<affiliation wicri:level="3">
<nlm:aff id="A7">Aix Marseille University, CNRS, ICR, UMR 7273, Marseille 13013, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix Marseille University, CNRS, ICR, UMR 7273, Marseille 13013</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chitambar, Christopher R" sort="Chitambar, Christopher R" uniqKey="Chitambar C" first="Christopher R." last="Chitambar">Christopher R. Chitambar</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A4">Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Dwinell, Michael B" sort="Dwinell, Michael B" uniqKey="Dwinell M" first="Michael B." last="Dwinell">Michael B. Dwinell</name>
<affiliation wicri:level="1">
<nlm:aff id="A3">Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A5">Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A6">Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kalyanaraman, Balaraman" sort="Kalyanaraman, Balaraman" uniqKey="Kalyanaraman B" first="Balaraman" last="Kalyanaraman">Balaraman Kalyanaraman</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A2">Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A3">Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">31191823</idno>
<idno type="pmc">6544408</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544408</idno>
<idno type="RBID">PMC:6544408</idno>
<idno type="doi">10.18632/oncotarget.26943</idno>
<date when="2019">2019</date>
<idno type="wicri:Area/Pmc/Corpus">000755</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000755</idno>
<idno type="wicri:Area/Pmc/Curation">000755</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000755</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000373</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000373</idno>
<idno type="wicri:Area/Ncbi/Merge">000695</idno>
<idno type="wicri:Area/Ncbi/Curation">000695</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000695</idno>
<idno type="wicri:Area/Main/Merge">000414</idno>
<idno type="wicri:Area/Main/Curation">000414</idno>
<idno type="wicri:Area/Main/Exploration">000414</idno>
<idno type="wicri:Area/France/Extraction">000031</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators</title>
<author>
<name sortKey="Cheng, Gang" sort="Cheng, Gang" uniqKey="Cheng G" first="Gang" last="Cheng">Gang Cheng</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A2">Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zielonka, Jacek" sort="Zielonka, Jacek" uniqKey="Zielonka J" first="Jacek" last="Zielonka">Jacek Zielonka</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A2">Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A3">Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hardy, Micael" sort="Hardy, Micael" uniqKey="Hardy M" first="Micael" last="Hardy">Micael Hardy</name>
<affiliation wicri:level="3">
<nlm:aff id="A7">Aix Marseille University, CNRS, ICR, UMR 7273, Marseille 13013, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix Marseille University, CNRS, ICR, UMR 7273, Marseille 13013</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ouari, Olivier" sort="Ouari, Olivier" uniqKey="Ouari O" first="Olivier" last="Ouari">Olivier Ouari</name>
<affiliation wicri:level="3">
<nlm:aff id="A7">Aix Marseille University, CNRS, ICR, UMR 7273, Marseille 13013, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix Marseille University, CNRS, ICR, UMR 7273, Marseille 13013</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chitambar, Christopher R" sort="Chitambar, Christopher R" uniqKey="Chitambar C" first="Christopher R." last="Chitambar">Christopher R. Chitambar</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A4">Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Dwinell, Michael B" sort="Dwinell, Michael B" uniqKey="Dwinell M" first="Michael B." last="Dwinell">Michael B. Dwinell</name>
<affiliation wicri:level="1">
<nlm:aff id="A3">Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A5">Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A6">Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kalyanaraman, Balaraman" sort="Kalyanaraman, Balaraman" uniqKey="Kalyanaraman B" first="Balaraman" last="Kalyanaraman">Balaraman Kalyanaraman</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A2">Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="A3">Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226</wicri:regionArea>
<wicri:noRegion>WI 53226</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Oncotarget</title>
<idno type="eISSN">1949-2553</idno>
<imprint>
<date when="2019">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<title>ABSTRACT</title>
<p>We demonstrate that combined treatment with metformin (Met) or its mitochondria-targeted analog, mito-metformin (Mito-Met), and various iron chelators synergistically inhibits proliferation of pancreatic and triple-negative breast cancer cells. Previously, we reported that Met (at millimolar levels) and Mito-Met (at micromolar levels) inhibited pancreatic cancer cell proliferation. Inhibition of mitochondrial complex I and mitochondrial oxidative phosphorylation (OXPHOS) through stimulation of mitochondrial redox signaling was proposed as a key mechanism for decreased cancer cell proliferation. Because of its poor bioavailability, the use of Met as a “stand-alone” antitumor drug has been questioned. Iron chelators such as deferasirox (DFX) and dexrazoxane (DXR) exhibit antiproliferative effects in cancer cells. The potency of Met and Mito-Met was synergistically enhanced in the presence of iron chelators, DFX, N,N'-bis(2-hydroxyphenyl)ethylendiamine-N,N'-diacetic acid (HBED), and deferoxamine (DFO). Met, DXR (also ICRF-187), and DFO are FDA-approved drugs for treating diabetes, decreasing the incidence and severity of cardiotoxicity following chemotherapy, and mitigating iron toxicity, respectively. Thus, the synergistic antiproliferative effects of Met and Met analogs and iron chelators may have significant clinical relevance in cancer treatment. These findings may have implications in other OXPHOS-mediated cancer therapies.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Provence-Alpes-Côte d'Azur</li>
</region>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Cheng, Gang" sort="Cheng, Gang" uniqKey="Cheng G" first="Gang" last="Cheng">Gang Cheng</name>
</noRegion>
<name sortKey="Cheng, Gang" sort="Cheng, Gang" uniqKey="Cheng G" first="Gang" last="Cheng">Gang Cheng</name>
<name sortKey="Chitambar, Christopher R" sort="Chitambar, Christopher R" uniqKey="Chitambar C" first="Christopher R." last="Chitambar">Christopher R. Chitambar</name>
<name sortKey="Chitambar, Christopher R" sort="Chitambar, Christopher R" uniqKey="Chitambar C" first="Christopher R." last="Chitambar">Christopher R. Chitambar</name>
<name sortKey="Dwinell, Michael B" sort="Dwinell, Michael B" uniqKey="Dwinell M" first="Michael B." last="Dwinell">Michael B. Dwinell</name>
<name sortKey="Dwinell, Michael B" sort="Dwinell, Michael B" uniqKey="Dwinell M" first="Michael B." last="Dwinell">Michael B. Dwinell</name>
<name sortKey="Dwinell, Michael B" sort="Dwinell, Michael B" uniqKey="Dwinell M" first="Michael B." last="Dwinell">Michael B. Dwinell</name>
<name sortKey="Kalyanaraman, Balaraman" sort="Kalyanaraman, Balaraman" uniqKey="Kalyanaraman B" first="Balaraman" last="Kalyanaraman">Balaraman Kalyanaraman</name>
<name sortKey="Kalyanaraman, Balaraman" sort="Kalyanaraman, Balaraman" uniqKey="Kalyanaraman B" first="Balaraman" last="Kalyanaraman">Balaraman Kalyanaraman</name>
<name sortKey="Kalyanaraman, Balaraman" sort="Kalyanaraman, Balaraman" uniqKey="Kalyanaraman B" first="Balaraman" last="Kalyanaraman">Balaraman Kalyanaraman</name>
<name sortKey="Zielonka, Jacek" sort="Zielonka, Jacek" uniqKey="Zielonka J" first="Jacek" last="Zielonka">Jacek Zielonka</name>
<name sortKey="Zielonka, Jacek" sort="Zielonka, Jacek" uniqKey="Zielonka J" first="Jacek" last="Zielonka">Jacek Zielonka</name>
<name sortKey="Zielonka, Jacek" sort="Zielonka, Jacek" uniqKey="Zielonka J" first="Jacek" last="Zielonka">Jacek Zielonka</name>
</country>
<country name="France">
<region name="Provence-Alpes-Côte d'Azur">
<name sortKey="Hardy, Micael" sort="Hardy, Micael" uniqKey="Hardy M" first="Micael" last="Hardy">Micael Hardy</name>
</region>
<name sortKey="Ouari, Olivier" sort="Ouari, Olivier" uniqKey="Ouari O" first="Olivier" last="Ouari">Olivier Ouari</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000031 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000031 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     PMC:6544408
   |texte=   Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:31191823" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021